Bottom line
Is ABLS a good fund? The bottom line
ABLS is a managed small-cap ETF from Abacus Fcf.
Its expense ratio is 0.39% — about $39 a year on every $10,000 invested, cheaper than 91% of small-cap funds we track.
It returned +9.3% over one year (as of Dec 31, 2024, per its prospectus).
With $464,508 in net assets and 48 holdings, its largest position is Argan Inc (11.8%) and the top 10 make up 50.1% of the portfolio.
What stands out
- Low cost: cheaper than 91% of small-cap peers
What to watch
- Concentrated: top 10 holdings are 50.1% of assets
- Small fund ($464,508) — small funds are likelier to close
Updated Nov 19, 2026
What ABLS invests in
The Abacus FCF Small Cap Leaders ETF (the Fund) seeks to provide investment results that correspond, before fees and expenses, generally to the performance of the Abacus FCF Small Cap Leaders Index (the Underlying Index).
The Underlying Index utilizes the Advisers proprietary Abacus FCF Leaders Model (the Model) to evaluate Eligible Securities and scores them based on FCF characteristics, including FCF profitability (the level of free cash flow a company generates relative to the size of its assets), FCF yield (free cash flow relative to the company's enterprise value) and FCF growth (the growth in a company's free cash flow over time). These securities are assigned active weights primarily based on their FCF characteristics. These active weights are integrated with free-float market capitalization weights and rescaled to construct the final portfolio, seeking to ensure high-conviction exposure to companies with strong FCF characteristics. The Underlying Index includes those remaining Eligible Securities until one of the following thresholds is met: (1) over 90% of the cumulative weight of the Eligible…
From the fund's prospectus (filed Oct 21, 2026).
ABLS performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| ABLS | +9.3% | — | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2024
What ABLS costs
On a $10,000 investment, ABLS's 0.39% expense ratio costs about $39 a year. The prospectus estimates $719 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
ABLS top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Argan Inc AGX | 11.79% |
| 2 | Enova International Inc ENVA | 6.46% |
| 3 | Oscar Health Inc OSCR | 5.83% |
| 4 | Artisan Partners Asset Managem APAM | 4.38% |
| 5 | Collegium Pharmaceutical Inc COLL | 4.27% |
| 6 | Healthcare Services Group Inc HCSG | 3.73% |
| 7 | Harmony Biosciences Holdings I HRMY | 3.58% |
| 8 | Qualys Inc QLYS | 3.40% |
| 9 | Kontoor Brands Inc KTB | 3.39% |
| 10 | Progyny Inc PGNY | 3.32% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 50.1% of the fund. See all top 25 holdings and asset mix →